Plasma urate and Parkinson's disease in women
- PMID: 20682521
- PMCID: PMC2950819
- DOI: 10.1093/aje/kwq195
Plasma urate and Parkinson's disease in women
Abstract
Plasma urate has been consistently associated with a lower risk of Parkinson's disease in men, but it is less clear if this relation exists in women. Between 1990 and 2004, the authors conducted a nested case-control study among participants of the female-only Nurses' Health Study. In controls (n = 504), plasma urate was positively associated with age, body mass index, alcohol consumption, hypertension, and use of diuretics and was inversely associated with physical activity and postmenopausal hormone use, as expected. Mean urate levels were 5.04 mg/dL for cases (n = 101) and 4.86 mg/dL for controls (P = 0.17). The age-, smoking-, and caffeine-adjusted rate ratio comparing women in the highest (≥5.8 mg/dL) with those in the lowest (<4.0 mg/dL) quartile was 1.33 (95% confidence interval: 0.69, 2.57; P(trend) = 0.4). Further adjustment for body mass index, physical activity, history of hypertension, and postmenopausal hormone use did not change the results. Unlike in men, these findings do not support the hypothesis that urate is strongly associated with lower rates of Parkinson's disease among women.
Similar articles
-
Plasma urate and risk of Parkinson's disease.Am J Epidemiol. 2007 Sep 1;166(5):561-7. doi: 10.1093/aje/kwm127. Epub 2007 Jun 20. Am J Epidemiol. 2007. PMID: 17584757 Free PMC article.
-
Diet, urate, and Parkinson's disease risk in men.Am J Epidemiol. 2008 Apr 1;167(7):831-8. doi: 10.1093/aje/kwm385. Epub 2008 Mar 7. Am J Epidemiol. 2008. PMID: 18326873 Free PMC article.
-
Plasma urate and Parkinson's disease in the Atherosclerosis Risk in Communities (ARIC) study.Am J Epidemiol. 2009 May 1;169(9):1064-9. doi: 10.1093/aje/kwp033. Epub 2009 Mar 18. Am J Epidemiol. 2009. PMID: 19299404 Free PMC article.
-
Urate as a marker of development and progression in Parkinson's disease.Drugs Today (Barc). 2011 May;47(5):369-80. doi: 10.1358/dot.2011.47.5.1591834. Drugs Today (Barc). 2011. PMID: 22013567 Review.
-
Uric acid in Parkinson's disease.Mov Disord. 2008 Sep 15;23(12):1653-7. doi: 10.1002/mds.22139. Mov Disord. 2008. PMID: 18618666 Review.
Cited by
-
Urate in Parkinson's disease: more than a biomarker?Curr Neurol Neurosci Rep. 2012 Aug;12(4):367-75. doi: 10.1007/s11910-012-0282-7. Curr Neurol Neurosci Rep. 2012. PMID: 22580741 Review.
-
Integration of risk factors for Parkinson disease in 2 large longitudinal cohorts.Neurology. 2018 May 8;90(19):e1646-e1653. doi: 10.1212/WNL.0000000000005473. Epub 2018 Apr 11. Neurology. 2018. PMID: 29643081 Free PMC article.
-
Habitual intake of dietary flavonoids and risk of Parkinson disease.Neurology. 2012 Apr 10;78(15):1138-45. doi: 10.1212/WNL.0b013e31824f7fc4. Epub 2012 Apr 4. Neurology. 2012. PMID: 22491871 Free PMC article.
-
Risk of dementia or Parkinson's disease in the presence of Sjögren's syndrome: A systematic review and meta-analysis.Front Integr Neurosci. 2022 Nov 7;16:1027044. doi: 10.3389/fnint.2022.1027044. eCollection 2022. Front Integr Neurosci. 2022. PMID: 36420122 Free PMC article.
-
Serum gamma-glutamyltransferase activity and Parkinson's disease risk in men and women.Sci Rep. 2020 Jan 27;10(1):1258. doi: 10.1038/s41598-020-58306-x. Sci Rep. 2020. PMID: 31988422 Free PMC article.
References
-
- Jenner P. Oxidative stress and Parkinson's disease. Handb Clin Neurol. 2007;83:507–520. - PubMed
-
- Davis JW, Grandinetti A, Waslien CI, et al. Observations on serum uric acid levels and the risk of idiopathic Parkinson's disease. Am J Epidemiol. 1996;144(5):480–484. - PubMed
-
- de Lau LM, Koudstaal PJ, Hofman A, et al. Serum uric acid levels and the risk of Parkinson disease. Ann Neurol. 2005;58(5):797–800. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical